Vivo Capital Surplus Fund VIII, L.P., 10% Owner at IMPEL PHARMACEUTICALS INC (IMPL), sold 575,000 shares at $0.29 ($74K) on 2023-12-15, disclosed to the SEC on 2023-12-19.
Open-market sale of $74k IMPL by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.29 | 12,066 | $3K | 4.7% |
| 2 | $0.29 | 87,934 | $26K | 34.4% |
| 3 | $0.11 | 28,682 | $3K | 4.3% |
| 4 | $0.11 | 209,029 | $23K | 31.0% |
| 5 | $0.08 | 28,632 | $2K | 3.1% |
| 6 | $0.08 | 208,657 |
| $17K |
| 22.5% |
| Total | $0.13 avg | 575,000 | $74K | 100% |
| Filing → |
| IMPL | BUY | 2021-04-29 | $8.6M | — | Filing → |
| ALGS | BUY | 2020-10-20 | $8.3M | — | Filing → |
| CRNX | SELL | 2020-04-17 | $10.1M | — | Filing → |